Back to search

Article

Lipidated macrocyclic peptide S-880008 as a broad-spectrum SARS-CoV-2 fusion inhibitor

2025-02-14

Abstract excerpt

<title>Abstract</title> <p>Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a threat to public health and the economy. Although several SARS-CoV-2 vaccines exist, they have failed to elicit effective neutralizing antibody responses against emerging SARS-CoV-2 variants harboring spike protein mutations. Moreover, while certain neutralizing-antibody-based the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
456cceb3-49d1-5049-bc4b-967e6e9bfd99
DOI
10.21203/rs.3.rs-5977541/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lipidated macrocyclic peptide S-880008 as a broad-spectrum SARS-CoV-2 fusion inhibitorDOI 10.21203/rs.3.rs-5977541/v1
Select a neighboring publication to make it the new centre.